This invention provides potassium channel modulators which are compounds of formula I
where at least one of W and Z is N;
where the moiety
is one of Groups A or B below
A
where Ar is a 1,2-fused, six membered ring aromatic group, bearing substituents R
1
and R
2
as defined below, and containing zero or one ring nitrogen atom; and where other substituents are defined herein.
The invention also provides a composition comprising a pharmaceutically acceptable carrier and at least one of the following: i) a pharmaceutically effective amount of a compound of formula I and ii) a pharmaceutically acceptable salt, ester, or prodrug thereof. The invention also provides a method of preventing or treating a disease or disorder which is affected by activities of potassium channels, comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula I or a salt, ester, or prodrug thereof.
这项发明提供了
钾通道调节剂,其化合物为公式I,其中W和Z中至少有一个是N;其中基团为下面的A或B之一:
A
其中Ar是一个1,2-融合的六元环芳香基团,带有以下定义的取代基R1和R2,并含有零个或一个环氮原子;其他取代基在此处定义。
该发明还提供了一种组合物,包括一种药学上可接受的载体和以下至少一种:i) 公式I的化合物的药学有效量,以及ii) 其药学上可接受的盐、酯或前药。 该发明还提供了一种预防或治疗受
钾通道活动影响的疾病或紊乱的方法,包括向有需要的患者施用公式I的化合物或其盐、酯或前药的治疗有效量。